NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Avelios Medical

Avelios Medical

Private
MunichHealthcare & Life Scienceshttps://www.avelios.com/en

Last Round

Strategic

May 6, 2026

Total Funding Raised

$38.82M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Avelios Medical is a healthtech company that provides a modular software platform intended to digitize and optimize hospital workflows and enable data-driven patient care.

Sector

Healthcare & Life Sciences

Verticals

EHR & EMR, Workflow Automation, Document Management

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

hospital information systemHISclinical workplaceclinical documentationelectronic medical recordEMRworkflow automationAI medical scribeclinical data managementSaaS healthcarediagnostic supportfederated learninghealth techdigital healthhospital software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avelios Medical Comparables

Compare Avelios Medical with similar companies based on industry and business-model similarity.

Avelios Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Meierhofer AG
81%
NEXUS AG
74%
CompuGroup Medical
73%

Avelios Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 6, 2026
Early FundingFeb 25, 2026
Series AFeb 6, 2025
GrantMar 30, 2023
GrantJan 11, 2023
Seed
Nov 2, 2021

Key People

Founding team and executive leadership

Christian Albrecht

Co-Founder CEO

Founding Team

Avelios Medical Investors

Notable investors and investment history

Avelios Medical investors
InvestorRounds
Revent CapitalSeries A, Seed
European Innovation Council FundGrant
zwei.7Series A
Sequoia CapitalSeries A
High-Tech GründerfondsSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Grew 23% QoQ, from 173 to 212 employees.

  • May 6, 2026

    Funding round included investors Fresenius SE & Co. KGaA and SAP.

Avelios Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avelios Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avelios Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMunich
Employee Range212
Year Founded2020
Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.